Literature DB >> 17101911

Altered mesolimbocortical and thalamic dopamine in Tourette syndrome.

D L Gilbert1, B T Christian, M J Gelfand, B Shi, J Mantil, F R Sallee.   

Abstract

We used [F-18]fallypride PET in six adults with Tourette syndrome and age-matched controls to assess extrastriatal dopamine 2 (D2) receptors. D2 receptor availability was significantly lower in the orbitofrontal cortex, primary motor cortex, anterior cingulate gyrus, mediodorsal nucleus of thalamus, and hippocampus, areas important for motivation and reward, sensory gating, movement, and attention. Altered dopaminergic function in mesolimbocortical systems and thalamus may contribute to increased motivational salience of tics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101911     DOI: 10.1212/01.wnl.0000242733.18534.2c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

2.  Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony.

Authors:  Kafui Dzirasa; H Westley Phillips; Tatyana D Sotnikova; Ali Salahpour; Sunil Kumar; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.

Authors:  Sarah A Eisenstein; Jon M Koller; Marilyn Piccirillo; Ana Kim; Jo Ann V Antenor-Dorsey; Tom O Videen; Abraham Z Snyder; Morvarid Karimi; Stephen M Moerlein; Kevin J Black; Joel S Perlmutter; Tamara Hershey
Journal:  Synapse       Date:  2012-05-15       Impact factor: 2.562

Review 4.  The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?

Authors:  M Bortolato; R Frau; S C Godar; L J Mosher; S Paba; F Marrosu; P Devoto
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

5.  Altered motor network activation and functional connectivity in adult Tourette's syndrome.

Authors:  Cornelius J Werner; Tony Stöcker; Thilo Kellermann; Jessica Bath; Margarete Beldoch; Frank Schneider; Hans Peter Wegener; Jon N Shah; Irene Neuner
Journal:  Hum Brain Mapp       Date:  2011-01-21       Impact factor: 5.038

6.  Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli.

Authors:  Andrea Kobiella; Sabine Vollstädt-Klein; Mira Bühler; Caroline Graf; Hans-Georg Buchholz; Nina Bernow; Igor Y Yakushev; Christian Landvogt; Mathias Schreckenberger; Gerhard Gründer; Peter Bartenstein; Christoph Fehr; Michael N Smolka
Journal:  Hum Brain Mapp       Date:  2010-05       Impact factor: 5.038

7.  Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.

Authors:  Stefano Palminteri; Maël Lebreton; Yulia Worbe; David Grabli; Andreas Hartmann; Mathias Pessiglione
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-22       Impact factor: 11.205

8.  The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.

Authors:  Bradley T Christian; Nicholas T Vandehey; Andrew S Fox; Dhanabalan Murali; Terrence R Oakes; Alex K Converse; Robert J Nickles; Steve E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Neuroimage       Date:  2008-10-29       Impact factor: 6.556

Review 9.  Animal models of tic disorders: a translational perspective.

Authors:  Sean C Godar; Laura J Mosher; Giuseppe Di Giovanni; Marco Bortolato
Journal:  J Neurosci Methods       Date:  2014-09-20       Impact factor: 2.390

10.  Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome.

Authors:  Alicja Lerner; Anto Bagic; Janine M Simmons; Zoltan Mari; Omer Bonne; Ben Xu; Diane Kazuba; Peter Herscovitch; Richard E Carson; Dennis L Murphy; Wayne C Drevets; Mark Hallett
Journal:  Brain       Date:  2012-05-10       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.